Nimble gen systems has been acquired
Roche to
Acquire NimbleGen for $272.5M, Eyes Additional Genomic
Vendors
NEWSBRIEF
Genetics suppliers (the shovels) for the genomics and diagnostics business are going to be big winners in the next 3-7 years. The time to buy for hedge funds or pharma is now.